Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	propionyl-CoA carboxylase activity	PCCA PCCB	4.47e-05	2	134	2	GO:0004658
Domain	IGv	HSPG2 OBSCN BTNL2 BTN2A3P CTLA4 ALCAM IGSF3	8.12e-07	75	128	7	SM00406
Domain	Ig-like_fold	HSPG2 IL13RA2 ADAMTSL1 MYOT INSRR OBSCN DCC IL22RA1 CD80 NTM BTNL2 BTN2A3P CTLA4 ALCAM TNR IGSF3	2.66e-05	706	128	16	IPR013783
Domain	-	HSPG2 IL13RA2 ADAMTSL1 MYOT INSRR OBSCN DCC IL22RA1 CD80 NTM BTNL2 CTLA4 ALCAM TNR IGSF3	4.93e-05	663	128	15	2.60.40.10
Domain	Ig_V-set	HSPG2 OBSCN CD80 BTNL2 BTN2A3P CTLA4 ALCAM IGSF3	6.92e-05	199	128	8	IPR013106
Domain	SAPS	PPP6R1 PPP6R3	1.39e-04	3	128	2	IPR007587
Domain	-	PYCR1 PYCR2	1.39e-04	3	128	2	1.10.3730.10
Domain	P5CR_dimer	PYCR1 PYCR2	1.39e-04	3	128	2	PF14748
Domain	P5CR_dimer	PYCR1 PYCR2	1.39e-04	3	128	2	IPR029036
Domain	SAPS	PPP6R1 PPP6R3	1.39e-04	3	128	2	PF04499
Domain	IG_LIKE	HSPG2 ADAMTSL1 MYOT OBSCN DCC CD80 NTM BTNL2 BTN2A3P CTLA4 ALCAM IGSF3	1.43e-04	491	128	12	PS50835
Domain	IG	HSPG2 ADAMTSL1 MYOT OBSCN DCC CD80 NTM BTNL2 CTLA4 ALCAM IGSF3	1.54e-04	421	128	11	SM00409
Domain	Ig_sub	HSPG2 ADAMTSL1 MYOT OBSCN DCC CD80 NTM BTNL2 CTLA4 ALCAM IGSF3	1.54e-04	421	128	11	IPR003599
Domain	Ig-like_dom	HSPG2 ADAMTSL1 MYOT OBSCN DCC CD80 NTM BTNL2 BTN2A3P CTLA4 ALCAM IGSF3	1.79e-04	503	128	12	IPR007110
Domain	IGc2	HSPG2 ADAMTSL1 MYOT OBSCN DCC NTM ALCAM IGSF3	2.18e-04	235	128	8	SM00408
Domain	Ig_sub2	HSPG2 ADAMTSL1 MYOT OBSCN DCC NTM ALCAM IGSF3	2.18e-04	235	128	8	IPR003598
Domain	P5CR	PYCR1 PYCR2	2.77e-04	4	128	2	PS00521
Domain	Pyrroline-COOH_reductase	PYCR1 PYCR2	2.77e-04	4	128	2	IPR000304
Domain	V-set	HSPG2 CD80 BTNL2 BTN2A3P CTLA4 ALCAM IGSF3	2.79e-04	184	128	7	PF07686
Domain	Thbox_rcpt	PTGER2 PTGFR	4.60e-04	5	128	2	IPR001105
Domain	ProC_N	PYCR1 PYCR2	9.57e-04	7	128	2	IPR028939
Domain	F420_oxidored	PYCR1 PYCR2	9.57e-04	7	128	2	PF03807
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RALGAPA1 CCDC18 TRIOBP PTPN23 CCT7 CACHD1 PPP6R1 EYA1 KIF7 WWC2 NCAPG IPO9 SEC24B CPSF1 PYCR1 RAI14 CRYBG3 PYCR2 PPP6R3 PCNT FTSJ3	1.33e-09	1049	139	21	27880917
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NELFCD ZDBF2 PPP6R1 SPAG5 RLF ZNF608 GCC2 RAI14 CRYBG3 PCCA PCCB PCNT	1.31e-07	418	139	12	34709266
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 DPP6 CARMIL1 ANXA6 OBSCN TRIOBP ACVR2B BDH1 RLF ASAP2 ZNF608 GCC2 PRKN RAI14 ALCAM GREB1 ERMARD PCCA GLIS1 TRAPPC9 PCNT	5.11e-07	1489	139	21	28611215
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	SESTD1 TAGAP EYA1 DCC IL22RA1 TAF3 ACSBG1 CD80 GREB1	1.31e-06	265	139	9	19240061
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CARMIL1 ANXA6 ITSN1 PTPN23 CCT7 SORBS1 SPAG5 KIF7 SEC24B PCCA PCCB PPP6R3 TRDMT1 PCNT FTSJ3	1.80e-06	853	139	15	28718761
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TRIOBP CCT7 ZDBF2 SORBS1 PPP6R1 BDH1 ISOC2 SF3B1 ACSBG1 GLG1 FBXO41 TLN2 CRYBG3 PYCR2 PCCA PCCB IGSF3	3.26e-06	1139	139	17	36417873
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SESTD1 ITSN1 TRIOBP CCT7 SORBS1 CACHD1 DNAAF9 SCYL2 UBE4A FRY SF3B1 PCSK6 TLN2 RAI14 PCCB PREX1 PCNT	1.57e-05	1285	139	17	35914814
Pubmed	Expression of CD80 on cultured neonatal mice cardiomyocytes and attenuation of cytotoxic T lymphocyte-mediated lysis.	CD80 CTLA4	1.59e-05	2	139	2	24507064
Pubmed	Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP(2) and contractile FP receptors in the rat uterus.	PTGER2 PTGFR	1.59e-05	2	139	2	10684792
Pubmed	Overview of mutations in the PCCA and PCCB genes causing propionic acidemia.	PCCA PCCB	1.59e-05	2	139	2	10502773
Pubmed	Correction of the metabolic defect in propionic acidemia fibroblasts by microinjection of a full-length cDNA or RNA transcript encoding the propionyl-CoA carboxylase beta subunit.	PCCA PCCB	1.59e-05	2	139	2	8188292
Pubmed	Downregulation of protease-activated receptor-1 in human lung fibroblasts is specifically mediated by the prostaglandin E receptor EP2 through cAMP elevation and protein kinase A.	PTGER2 F2R	1.59e-05	2	139	2	18537828
Pubmed	Lentiviral gene transfer of CTLA4 generates B cells with reduced costimulatory properties.	CD80 CTLA4	1.59e-05	2	139	2	19811307
Pubmed	Mutation spectrum of the PCCA and PCCB genes in Japanese patients with propionic acidemia.	PCCA PCCB	1.59e-05	2	139	2	15059621
Pubmed	Isolation of cDNA clones coding for the alpha and beta chains of human propionyl-CoA carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA and PCCB genes.	PCCA PCCB	1.59e-05	2	139	2	3460076
Pubmed	Propionic acidemia: identification of twenty-four novel mutations in Europe and North America.	PCCA PCCB	1.59e-05	2	139	2	12559849
Pubmed	[Analysis of PCCA and PCCB gene mutations in patients with propionic acidemia].	PCCA PCCB	1.59e-05	2	139	2	25636094
Pubmed	EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway.	PTGER2 PTGFR	1.59e-05	2	139	2	19782748
Pubmed	Propionic Acidemia	PCCA PCCB	1.59e-05	2	139	2	22593918
Pubmed	Functional Analysis of the PCCA and PCCB Gene Variants Predicted to Affect Splicing.	PCCA PCCB	1.59e-05	2	139	2	33923806
Pubmed	Effect of PCCB gene mutations on the heteromeric and homomeric assembly of propionyl-CoA carboxylase.	PCCA PCCB	1.59e-05	2	139	2	11749052
Pubmed	Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.	CD80 CTLA4	1.59e-05	2	139	2	12355442
Pubmed	The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection.	CD80 CTLA4	1.59e-05	2	139	2	15008968
Pubmed	Identification of 34 novel mutations in propionic acidemia: Functional characterization of missense variants and phenotype associations.	PCCA PCCB	1.59e-05	2	139	2	30274917
Pubmed	Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1.	CD80 CTLA4	1.59e-05	2	139	2	8244464
Pubmed	CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease.	CD80 CTLA4	1.59e-05	2	139	2	26409459
Pubmed	Support for involvement of the AHI1 locus in schizophrenia.	AHI1-DT AHI1	1.59e-05	2	139	2	17473831
Pubmed	Two frequent mutations associated with the classic form of propionic acidemia in Taiwan.	PCCA PCCB	1.59e-05	2	139	2	24863100
Pubmed	Isolation and characterization of propionyl-CoA carboxylase from normal human liver. Evidence for a protomeric tetramer of nonidentical subunits.	PCCA PCCB	1.59e-05	2	139	2	6765947
Pubmed	AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia.	AHI1-DT AHI1	1.59e-05	2	139	2	16773125
Pubmed	New splicing mutations in propionic acidemia.	PCCA PCCB	1.59e-05	2	139	2	17051315
Pubmed	Seventeen Novel Mutations in PCCA and PCCB Genes in Indian Propionic Acidemia Patients, and Their Outcomes.	PCCA PCCB	1.59e-05	2	139	2	27227689
Pubmed	Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme A carboxylase.	PCCA PCCB	1.59e-05	2	139	2	20725044
Pubmed	Roles of prostaglandin receptors in female reproduction.	PTGER2 PTGFR	1.59e-05	2	139	2	25480981
Pubmed	Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder.	AHI1-DT AHI1	1.59e-05	2	139	2	20452750
Pubmed	Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.	CD80 CTLA4	1.59e-05	2	139	2	11279502
Pubmed	Propionyl-CoA carboxylase - A review.	PCCA PCCB	1.59e-05	2	139	2	29033250
Pubmed	B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice.	CD80 CTLA4	1.59e-05	2	139	2	12352894
Pubmed	Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.	DPP6 SORBS1 PTGFR FRY TAF3 PRKN CACNA1I	1.63e-05	199	139	7	23382691
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	DHX57 PPP6R1 TRAPPC8 DCC NCAPG IPO9 PELO PYCR1 RAI14 PYCR2 PPP6R3 PCNT	1.71e-05	670	139	12	22990118
Pubmed	Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly.	RALGAPA1 ITSN1 SCYL2	2.20e-05	14	139	3	16903783
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RALGAPA1 ITSN1 CCDC18 TRIOBP BBS2 PPP6R1 TRAPPC8 KIF7 UBE4A NCAPG SF3B1 GLG1 PYCR1 CRYBG3 PYCR2 PPP6R3 PCNT FTSJ3	2.82e-05	1487	139	18	33957083
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SESTD1 PDE4A ITSN1 TRIOBP SORBS1 PPP6R1 KIF7 FRY SF3B1 FBXO41 TLN2 FRMPD3 TNR PCNT	3.38e-05	963	139	14	28671696
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 NELFCD CARMIL1 CCDC18 SORBS1 WWC2 IPO9 IKBKE SEC24B RAI14 CRYBG3 TRAPPC9 OTOG	4.44e-05	861	139	13	36931259
Pubmed	The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.	CD80 CTLA4	4.75e-05	3	139	2	14724434
Pubmed	Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice.	CD80 CTLA4	4.75e-05	3	139	2	12244135
Pubmed	Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium.	AHI1-DT AHI1	4.75e-05	3	139	2	17668382
Pubmed	Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway.	F2R ELANE	4.75e-05	3	139	2	19307610
Pubmed	Revealing the atomistic details behind the binding of B7-1 to CD28 and CTLA-4: A comprehensive protein-protein modelling study.	CD80 CTLA4	4.75e-05	3	139	2	30251665
Pubmed	PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress.	PYCR1 PYCR2	4.75e-05	3	139	2	26733354
Pubmed	Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production.	PYCR1 PYCR2	4.75e-05	3	139	2	24930674
Pubmed	Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling.	CD80 CTLA4	4.75e-05	3	139	2	12606712
Pubmed	Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.	CD80 CTLA4	4.75e-05	3	139	2	10490971
Pubmed	DCC is expressed in a CD166-positive subpopulation of chondrocytes in human osteoarthritic cartilage and modulates CRE activity.	DCC ALCAM	4.75e-05	3	139	2	24966904
Pubmed	High-affinity small molecule inhibitors of T cell costimulation: compounds for immunotherapy.	CD80 CTLA4	4.75e-05	3	139	2	15610849
Pubmed	Dendritic Cell-Secreted Cytotoxic T-Lymphocyte-Associated Protein-4 Regulates the T-cell Response by Downmodulating Bystander Surface B7.	CD80 CTLA4	4.75e-05	3	139	2	26979751
Pubmed	Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.	CD80 CTLA4	4.75e-05	3	139	2	12429713
Pubmed	CTLA-4 regulates cell cycle progression during a primary immune response.	CD80 CTLA4	4.75e-05	3	139	2	11807776
Pubmed	Functional specialization in proline biosynthesis of melanoma.	PYCR1 PYCR2	4.75e-05	3	139	2	23024808
Pubmed	LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.	FER1L4 SOCS5	4.75e-05	3	139	2	31473323
Pubmed	Uncommon somatic mutations in metastatic NUT midline carcinoma.	DCC SF3B1	4.75e-05	3	139	2	28967088
Pubmed	Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis.	CD80 CTLA4	4.75e-05	3	139	2	22917707
Pubmed	Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.	CD80 CTLA4	4.75e-05	3	139	2	7504059
Pubmed	Genetic analysis of Pycr1 and Pycr2 in mice.	PYCR1 PYCR2	4.75e-05	3	139	2	33734376
Pubmed	Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.	CD80 CTLA4	4.75e-05	3	139	2	7545666
Pubmed	Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.	CD80 CTLA4	4.75e-05	3	139	2	7544393
Pubmed	Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.	CD80 CTLA4	4.75e-05	3	139	2	16002699
Pubmed	CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.	CD80 CTLA4	4.75e-05	3	139	2	15788440
Pubmed	Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-H gamma 1 transgenic mice.	CD80 CTLA4	4.75e-05	3	139	2	9647206
Pubmed	IL-17 receptor adaptor protein Act1/CIKS plays an evolutionarily conserved role in antiviral signaling.	TRAF3IP2 IKBKE	4.75e-05	3	139	2	23066157
Pubmed	The adaptor function of TRAPPC2 in mammalian TRAPPs explains TRAPPC2-associated SEDT and TRAPPC9-associated congenital intellectual disability.	TRAPPC8 TRAPPC9	4.75e-05	3	139	2	21858081
Pubmed	Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.	CD80 CTLA4	4.75e-05	3	139	2	11877291
Pubmed	In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.	CD80 CTLA4	4.75e-05	3	139	2	7515723
Pubmed	B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.	CD80 CTLA4	4.75e-05	3	139	2	9600957
Pubmed	The role of CTLA-4 in regulating Th2 differentiation.	CD80 CTLA4	4.75e-05	3	139	2	10453003
Pubmed	Genome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults.	AHI1-DT AHI1	4.75e-05	3	139	2	15169551
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	NELFCD PTPN23 MCM2 CCT7 SCYL2 NCAPG IPO9 SF3B1 PYCR1 PYCR2 PPP6R3	5.45e-05	638	139	11	33239621
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	OBSCN ZDBF2 CACHD1 WDFY4 PPP6R3	5.52e-05	101	139	5	10997877
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 TRIOBP MCM2 CACHD1 ZNF608 ACSBG1 FBXO41 RAI14 IGSF3 PPP6R3	5.63e-05	529	139	10	14621295
Pubmed	Human transcription factor protein interaction networks.	HSPG2 CCT7 PPP6R1 MYO5C KIF7 RLF ANGPTL6 TAF3 ZNF608 SEC24B CPSF1 RAI14 PCCA PCCB TRAPPC9 PPP6R3 FTSJ3	5.93e-05	1429	139	17	35140242
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	TRAF3IP2 SESTD1 AHI1 CARMIL1 BBS2 MCM2 BDH1 SPAG5 KIF7 SCYL2 ASAP2 IPO9 GCC2 SEC24B RAI14 TRAPPC9	8.06e-05	1321	139	16	27173435
Pubmed	Molecular patterning of the embryonic cranial mesenchyme revealed by genome-wide transcriptional profiling.	GPR17 SORBS1 EYA1 DCC	9.38e-05	59	139	4	31351040
Pubmed	Endorepellin remodels the endothelial transcriptome toward a pro-autophagic and pro-mitophagic gene signature.	HSPG2 PRKN	9.47e-05	4	139	2	29921586
Pubmed	CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation.	CD80 CTLA4	9.47e-05	4	139	2	15034031
Pubmed	Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.	CD80 CTLA4	9.47e-05	4	139	2	11826754
Pubmed	Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis.	CD80 CTLA4	9.47e-05	4	139	2	10477557
Pubmed	Replicative verification of susceptibility genes previously identified from families with segregating developmental dysplasia of the hip.	HSPG2 PTGFR	9.47e-05	4	139	2	34174923
Pubmed	Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.	CD80 CTLA4	9.47e-05	4	139	2	10679081
Pubmed	The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.	CD80 CTLA4	9.47e-05	4	139	2	17513738
Pubmed	Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease.	CD80 CTLA4	9.47e-05	4	139	2	17429849
Pubmed	B7-deficient autoreactive T cells are highly susceptible to suppression by CD4(+)CD25(+) regulatory T cells.	CD80 CTLA4	9.47e-05	4	139	2	17237403
Pubmed	Mitochondrial targeting signals and mature peptides of 3-methylcrotonyl-CoA carboxylase.	PCCA PCCB	9.47e-05	4	139	2	16023992
Pubmed	Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.	CD80 CTLA4	9.47e-05	4	139	2	12835481
Pubmed	Role of the Rho GTPase-activating protein RICS in neurite outgrowth.	PPP6R1 PPP6R3	9.47e-05	4	139	2	16716191
Pubmed	Human protein phosphatase PP6 regulatory subunits provide Sit4-dependent and rapamycin-sensitive sap function in Saccharomyces cerevisiae.	PPP6R1 PPP6R3	9.47e-05	4	139	2	19621075
Pubmed	B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.	CD80 CTLA4	9.47e-05	4	139	2	11929778
Pubmed	Cloning and sequencing of the rabbit gene encoding T-cell costimulatory molecules.	CD80 CTLA4	9.47e-05	4	139	2	7642234
Pubmed	Optimization of RNA isolation from human ocular tissues and analysis of prostanoid receptor mRNA expression using RT-PCR.	PTGER2 PTGFR	9.47e-05	4	139	2	11951086
Pubmed	Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.	CD80 CTLA4	9.47e-05	4	139	2	16148116
Pubmed	B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.	CD80 CTLA4	9.47e-05	4	139	2	11285307
Interaction	ANAPC2 interactions	NELFCD CCDC18 CCT7 SPAG5 MYO5C KIF7 GCC2 PYCR1 PYCR2 PCNT	3.81e-06	234	134	10	int:ANAPC2
Interaction	AP2B1 interactions	RALGAPA1 ITSN1 CCDC18 PTPN23 MCM2 WDFY4 SCYL2 CFAP54 GCC2 PRKN PPP6R3 PCNT	7.52e-06	373	134	12	int:AP2B1
Interaction	PXN interactions	CCDC18 PTPN23 SORBS1 KIF7 SCYL2 ASAP2 GCC2 PYCR1 PRKN CRYBG3 PCNT	1.47e-05	334	134	11	int:PXN
Interaction	PHF21A interactions	NELFCD ZDBF2 PPP6R1 SPAG5 RLF GCC2 RAI14 CRYBG3 PCCA PCCB PCNT	1.89e-05	343	134	11	int:PHF21A
Interaction	PEX14 interactions	NELFCD ITSN1 CCT7 SPAG5 MYO5C SCYL2 NEU2 GCC2 PCNT	3.01e-05	237	134	9	int:PEX14
Interaction	PFN1 interactions	CARMIL1 ITSN1 MCM2 EYA1 SPAG5 MYO5C KIF7 SCYL2 GCC2 SEC24B PRKN CRYBG3 PCNT	3.58e-05	509	134	13	int:PFN1
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HSPG2 ADAMTSL1 MYOT OBSCN DCC NTM	1.53e-04	161	90	6	593
GeneFamily	Protein phosphatase 6 regulatory subunits	PPP6R1 PPP6R3	3.63e-04	6	90	2	699
GeneFamily	Prostaglandin (prostanoid) receptors	PTGER2 PTGFR	8.62e-04	9	90	2	207
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	CD80 BTNL2 ALCAM	1.03e-03	40	90	3	592
GeneFamily	Adenosine receptors\|V-set domain containing	CD80 BTNL2 CTLA4 ALCAM IGSF3	1.33e-03	163	90	5	590
GeneFamily	Trafficking protein particle complex	TRAPPC8 TRAPPC9	2.14e-03	14	90	2	772
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTNL2 BTN2A3P	2.47e-03	15	90	2	458
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ITSN1 OBSCN PREX1	4.35e-03	66	90	3	722
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K2	ARHGAP40 IL22RA1 MYO5C DUOX1 ACSBG1 FER1L4 PLK3	6.96e-06	110	136	7	facebase_RNAseq_e10.5_Emin_MedNas_2500_K2
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3	TRAF3IP2 ANXA6 F2R SPAG5 NCAPG ACSBG1 IKBKE TMC8 CTLA4 ALCAM PREX1	2.98e-05	374	136	11	GSM538389_500
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HSPG2 ADAMTSL1 ID1 SHC3 MYO5C WWC2 ZNF608 ALCAM	1.28e-07	187	138	8	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAMTSL1 CACHD1 SHC3 MYO5C FRY ZNF608 RAI14 ALCAM	1.45e-07	190	138	8	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	ADAMTSL1 CACHD1 SHC3 MYO5C WWC2 ZNF608 RAI14 ALCAM	1.51e-07	191	138	8	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACHD1 PTGFR SHC3 MYO5C WWC2 DUOX1 ZNF608 RAI14	1.51e-07	191	138	8	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	CACHD1 PTGFR SHC3 MYO5C WWC2 DUOX1 RAI14 ALCAM	1.57e-07	192	138	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DPP6 CACHD1 DCC PTGFR SHC3 MYO5C DUOX1 RAI14	1.99e-07	198	138	8	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACHD1 PTGFR SHC3 MYO5C WWC2 DUOX1 RAI14 ALCAM	2.06e-07	199	138	8	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 DPP6 CARMIL1 ID1 EYA1 MYO5C ALCAM	1.36e-06	177	138	7	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC18 MCM2 SPAG5 LRR1 NCAPG BTNL2 ELANE	1.70e-06	183	138	7	6c1d7ce60e67bf1df364a4e177c351e7313eb41f
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCDC18 MCM2 SPAG5 LRR1 NCAPG BTNL2 ELANE	1.83e-06	185	138	7	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SESTD1 PDE4A CCDC168 DNAAF9 ACVR2B CD80 CTLA4	1.89e-06	186	138	7	bca5215d406f1785bf3a420201d5686071fcaca5
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL13RA2 GPR17 MCM2 F2R SPAG5 LRR1 PYCR1	1.96e-06	187	138	7	38ee33295a21db4aae5ba085df033db9693e41c6
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL13RA2 GPR17 MCM2 F2R SPAG5 LRR1 PYCR1	1.96e-06	187	138	7	dbcec24d2c852964736c78e9d81650bff5c455ae
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DPP6 CACHD1 PTGFR SHC3 MYO5C DUOX1 RAI14	2.26e-06	191	138	7	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAMTSL1 CACHD1 SHC3 MYO5C WWC2 ZNF608 ALCAM	2.26e-06	191	138	7	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	DPP6 CACHD1 PTGFR SHC3 MYO5C DUOX1 RAI14	2.34e-06	192	138	7	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACHD1 EYA1 MYO5C ZNF608 HES1 RAI14 ALCAM	2.34e-06	192	138	7	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACHD1 PTGFR MYO5C WWC2 DUOX1 RAI14 ALCAM	2.96e-06	199	138	7	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACHD1 PTGFR MYO5C WWC2 DUOX1 RAI14 ALCAM	2.96e-06	199	138	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_E\|390C / Donor, Lineage, Cell class and subclass (all cells)	TRAF3IP2 AHI1 BBS2 FBXO41 XCL1 PREX1	8.96e-06	155	138	6	98d8432739965dd1ab77c899cb6321f7f05eaa46
ToppCell	Control-Lymphocyte-T_NK-dnT\|Control / Disease, Lineage and Cell Type	TRAF3IP2 SESTD1 CACHD1 NCAPG CTLA4 GLIS1	1.00e-05	158	138	6	7a2fad6426549d910834debfe5e102fe2ab5976d
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CARMIL1 MAP3K7CL TRAPPC8 ZNF804A ALCAM FTSJ3	1.37e-05	167	138	6	a48349f189f6a8d563744b0a294c3974f3a18f50
ToppCell	facs-Brain_Myeloid-Striatum-24m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP40 OXGR1 FER1L4 C17orf78 C1QA XCL1	1.52e-05	170	138	6	626c12b9a51218f72ee32afb5fd5d4b075025d75
ToppCell	facs-Brain_Myeloid-Striatum-24m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP40 OXGR1 FER1L4 C17orf78 C1QA XCL1	1.52e-05	170	138	6	31daac8696ae8c021c0302d3b30dd8194054b3e7
ToppCell	facs-Brain_Myeloid-Striatum-24m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP40 OXGR1 FER1L4 C17orf78 C1QA XCL1	1.52e-05	170	138	6	ca88dc0b7a6960facb7c4d3c0f4795431a0a43d2
ToppCell	facs-Brain_Myeloid-Striatum-24m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP40 OXGR1 FER1L4 C17orf78 C1QA XCL1	1.52e-05	170	138	6	b6882665a27c78a63f3b4a2a8806c8438a98e407
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SORBS1 TMPRSS11F SHC3 MYO5C WWC2 ZNF608	1.67e-05	173	138	6	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C2orf69 TAGAP BDH1 IKBKE TMC8 XCL1	1.79e-05	175	138	6	a72c6ceca5ddbd34f652e7302defefa2d105e17e
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C2orf69 TAGAP BDH1 IKBKE TMC8 XCL1	1.79e-05	175	138	6	9a462e9e6f7bbb64abb09ad6c080df3576073540
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP6 CARMIL1 ID1 EYA1 MYO5C ALCAM	1.97e-05	178	138	6	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC18 MCM2 BDH1 NCAPG CTLA4 XCL1	1.97e-05	178	138	6	79823d13652177de852c2acce9159049241f1d86
ToppCell	T_cells-GZMK+_CD8+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	NELFCD F2R NCAPG C1QA FRMPD3 GLIS1	2.03e-05	179	138	6	798f208014f2229c597934775646ddbbacf94b69
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTSL1 SHC3 SPATA45 PCSK6 GLIS1 IGSF3	2.16e-05	181	138	6	b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTSL1 SHC3 SPATA45 PCSK6 GLIS1 IGSF3	2.16e-05	181	138	6	cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTSL1 SHC3 SPATA45 PCSK6 GLIS1 IGSF3	2.16e-05	181	138	6	ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 CETP ID1 SPAG5 NCAPG LPAR6	2.30e-05	183	138	6	52af3c943116073c8ddd207b664342960b88929b
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PDE4A CCDC168 DNAAF9 ACVR2B CD80 CTLA4	2.30e-05	183	138	6	3cbe0175d05fd39bc430de1ef471ff2c5b56460e
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	CACHD1 MYO5C DUOX1 ZNF608 RAI14 ALCAM	2.44e-05	185	138	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPP6 CARMIL1 ID1 EYA1 MYO5C ALCAM	2.44e-05	185	138	6	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 DPP6 CARMIL1 ID1 MYO5C WWC2	2.52e-05	186	138	6	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TRAF3IP2 WDFY4 ZBTB45 NCAPG CTLA4 ERMARD	2.52e-05	186	138	6	74eb69a52090f9e2426a47e03a1c478ee0cfec18
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Necab1_(MGE-derived_cortical_interneurons--basket_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ARHGAP40 DUOX1 FER1L4 XCL1	2.56e-05	55	138	4	ed871246b0ada07e8fe87a68584c06986977d0bd
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Necab1_(MGE-derived_cortical_interneurons--basket_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ARHGAP40 DUOX1 FER1L4 XCL1	2.56e-05	55	138	4	51a76e6cb45976ce99a41fb6cd5b94c632ec7c5b
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL13RA2 GPR17 F2R SPAG5 LRR1 PYCR1	2.59e-05	187	138	6	a2076599b33ae6750961b573bfebcb9036fa4ee8
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACHD1 PTGFR SHC3 MYO5C DUOX1 ALCAM	2.84e-05	190	138	6	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SORBS1 FRY PCSK6 HES1 TNR PREX1	3.01e-05	192	138	6	7197e401e563441ab94815f7619e032ebef9e586
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAMTSL1 SHC3 WWC2 DUOX1 ZNF608 ALCAM	3.01e-05	192	138	6	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5C WWC2 DUOX1 NTM RAI14 ALCAM	3.19e-05	194	138	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRAF3IP2 ZNF154 CCDC18 LRR1 XCL1 TRAPPC9	3.19e-05	194	138	6	5031f324628ff12a33e84cc52157be4786e0961d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DPP6 CARMIL1 PTGFR SHC3 DUOX1 RAI14	3.19e-05	194	138	6	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	OBSCN SORBS1 FRY ZNF608 NTM PRKN	3.19e-05	194	138	6	c3535f7cc0076653c72db582047cff053c322397
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANXA6 ID1 SORBS1 GREM2 NTM ALCAM	3.28e-05	195	138	6	26a3a5daf389606ef1ebb35533f12e60853b3a12
ToppCell	severe-T/NK_proliferative\|severe / disease stage, cell group and cell class	MCM2 VWA7 SPAG5 LRR1 NCAPG CTLA4	3.38e-05	196	138	6	89f005216770dbb84378f5d1f20ca11b0ce40faa
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ADAMTSL1 CACHD1 GREM2 GLG1 PCSK6	3.38e-05	196	138	6	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	Severe-CD4+_T\|Severe / Disease group and Cell class	TAGAP PTGER2 GREM2 FRY LPAR6 PLK3	3.38e-05	196	138	6	576e0aa2ae146a86201dea21097ffe1c867956e7
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ADAMTSL1 CACHD1 GREM2 GLG1 PCSK6	3.38e-05	196	138	6	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	severe-T/NK_proliferative\|World / disease stage, cell group and cell class	MCM2 VWA7 SPAG5 LRR1 NCAPG CTLA4	3.47e-05	197	138	6	6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTSL1 ARHGAP40 EYA1 ZNF608 HES1 ALCAM	3.57e-05	198	138	6	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ADAMTSL1 MYO5C FRY ZNF608 HES1 ALCAM	3.57e-05	198	138	6	1eb49b853a9e144e840c660060473fc7873f6478
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DPP6 CACHD1 PTGFR SHC3 DUOX1 RAI14	3.57e-05	198	138	6	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTSL1 ARHGAP40 EYA1 ZNF608 HES1 ALCAM	3.57e-05	198	138	6	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WDFY4 ZNF804A NCAPG LPAR6 FBXO41 C1QA	3.57e-05	198	138	6	732a43061d75bc5e1cf23f5056b72cd10c926668
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAMTSL1 ARHGAP40 EYA1 ZNF608 HES1 ALCAM	3.57e-05	198	138	6	6ba5e5970109a04ed968bac7ff099ae250c579dc
ToppCell	Caecum-T_cell-Th1\|T_cell / Region, Cell class and subclass	ITSN1 ACVR2B PTGER2 F2R BDH1 PLK3	3.67e-05	199	138	6	13a80e6d3cf9c831edbe0644545071153e35f82b
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTGFR MYO5C WWC2 DUOX1 RAI14 ALCAM	3.67e-05	199	138	6	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN ID1 CACHD1 EYA1 DUOX1 IGSF3	3.67e-05	199	138	6	94a7867e800df352731796de8c24cba133c29622
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	C2orf69 SPAG5 NCAPG IPO9 CPSF1 PCNT	3.78e-05	200	138	6	d933978b55fefe52cad599b36f6b47a0c7f71f96
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CARMIL1 ITSN1 SORBS1 CACHD1 EYA1 ACSBG1	3.78e-05	200	138	6	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CARMIL1 ITSN1 SORBS1 CACHD1 EYA1 ACSBG1	3.78e-05	200	138	6	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CARMIL1 ITSN1 SORBS1 CACHD1 EYA1 ACSBG1	3.78e-05	200	138	6	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DPP6 DCC ZNF804A SHC3 FRY TNR	3.78e-05	200	138	6	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DPP6 DCC ZNF804A SHC3 FRY TNR	3.78e-05	200	138	6	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DPP6 DCC ZNF804A SHC3 FRY TNR	3.78e-05	200	138	6	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	WDFY4 ANGPTL6 TMC8 C1QA PREX1 PLK3	3.78e-05	200	138	6	80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	C2orf69 SPAG5 NCAPG IPO9 CPSF1 PCNT	3.78e-05	200	138	6	3d932765c31aef1f80a118d51e8e66c50a758dbb
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CARMIL1 ITSN1 SORBS1 CACHD1 EYA1 ACSBG1	3.78e-05	200	138	6	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CARMIL1 ID1 SORBS1 FRY GCC2 PREX1	3.78e-05	200	138	6	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DPP6 DCC ZNF804A SHC3 FRY TNR	3.78e-05	200	138	6	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Biopsy_Control_(H.)-Immune-T_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	TAGAP ANXA6 PTGER2 F2R CTLA4 XCL1	3.78e-05	200	138	6	3545706d133b29df61affe8ac47b6c9fe85f7775
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CARMIL1 ITSN1 SORBS1 CACHD1 EYA1 ACSBG1	3.78e-05	200	138	6	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DPP6 DCC ZNF804A SHC3 FRY TNR	3.78e-05	200	138	6	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CARMIL1 ITSN1 SORBS1 CACHD1 EYA1 ACSBG1	3.78e-05	200	138	6	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DPP6 DCC ZNF804A SHC3 FRY TNR	3.78e-05	200	138	6	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	COVID-19_Mild-Neu_3\|World / 5 Neutrophil clusters in COVID-19 patients	PCDHGB3 OBSCN CCDC168 SPATA45 FRMPD3	3.92e-05	122	138	5	2aa9cfadab70312882ae679e3788fc7ab996c0f3
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tfh\|GI_small-bowel / Manually curated celltypes from each tissue	EYA1 DUOX1 PRKN CACNA1I CTLA4	6.14e-05	134	138	5	bf94ce5edde8912a27010e229c313d8102d6de62
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	INSRR TMC8 CACNA1I CTLA4 PREX1	1.01e-04	149	138	5	f4bee5fdaaa4a1917e403de90e5a62353006df24
ToppCell	normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	C2orf69 TAGAP ZDBF2 SPATA45 LPAR6	1.01e-04	149	138	5	a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f
ToppCell	10x5'-Lung-Myeloid_Monocytic-Cycling_mono\|Lung / Manually curated celltypes from each tissue	AHI1-DT MCM2 SPAG5 NCAPG ELANE	1.26e-04	156	138	5	63b8cf14361b282872bc1c5b65d9fbc83e81a089
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	MYOT PTGFR GREM2 ELANE PRKN	1.41e-04	160	138	5	8a41e2c96e0e170ac35daf6c403bf961b8d7c30b
ToppCell	TCGA-Bladder-Solid_Tissue_Normal\|TCGA-Bladder / Sample_Type by Project: Shred V9	MYOT PTGFR GREM2 ELANE PRKN	1.41e-04	160	138	5	d6678996e12eaf2b735f1dfae32418cb2fabf268
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	MYOT PTGFR GREM2 ELANE PRKN	1.41e-04	160	138	5	c8dc575562b463fd30832d322c28006f18f7ab9c
ToppCell	10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive\|bone_marrow / Manually curated celltypes from each tissue	IGKV1-6 PCDHGB3 WDFY4 CD80 HES1	1.50e-04	162	138	5	44832055b11a789e320c802aadb345e065defc8f
ToppCell	PSB-critical-LOC-Lymphoid-PC\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANXA6 DCC ZNF804A TMC8 PREX1	1.59e-04	164	138	5	3e672124dea2497c5bdf8a315c8cfacfab5780dc
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPP6 GPR17 F2R PYCR1 TNR	1.59e-04	164	138	5	0853e75b60b2a78257b660910c3ee15b09c5f5b0
ToppCell	facs-MAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS11F PTGER2 SHC3 NEU2 CTLA4	1.59e-04	164	138	5	e9e34c305c943675688e54ab331c2bdefb2fac68
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	AHI1-DT ADAMTSL1 EYA1 MYO5C CFAP54	1.63e-04	165	138	5	0c714e852f912b5749de4cb0895406673979b2e6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	AHI1-DT ADAMTSL1 EYA1 MYO5C CFAP54	1.63e-04	165	138	5	82530f96aaefe28a13bad0474bbad043f127a86c
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ADAMTSL1 SPAG5 NCAPG CD80 ALCAM	1.63e-04	165	138	5	4297588f809e8a8275ab1a6ed99daac7ad93bd61
ToppCell	COVID-CD8-exh_CD4\|COVID / Condition, Cell_class and T cell subcluster	TEPSIN PTPN23 ZDBF2 RLF XCL1	1.68e-04	166	138	5	4ca8c91b03d08489f244898cf9423b9d10348bc8
ToppCell	droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP MCM2 SPAG5 SOCS5 XCL1	1.68e-04	166	138	5	21ba5fd755c0fb31ada42a1b5d60bede0153323d
Disease	autosomal recessive cutis laxa type IIB (implicated_via_orthology)	PYCR1 PYCR2	2.05e-05	2	134	2	DOID:0070137 (implicated_via_orthology)
Disease	propionic acidemia (is_implicated_in)	PCCA PCCB	2.05e-05	2	134	2	DOID:14701 (is_implicated_in)
Disease	Propionicaciduria	PCCA PCCB	2.05e-05	2	134	2	C2717876
Disease	PROPIONIC ACIDEMIA	PCCA PCCB	2.05e-05	2	134	2	606054
Disease	Propionic acidemia	PCCA PCCB	2.05e-05	2	134	2	cv:C0268579
Disease	Propionic acidemia	PCCA PCCB	6.12e-05	3	134	2	C0268579
Disease	systemic lupus erythematosus	AHI1-DT PDE4A AHI1 CARMIL1 ANXA6 WDFY4 ZNF804A MYO5C IKBKE CD80 BTNL2 CTLA4	2.96e-04	799	134	12	MONDO_0007915
Disease	post-traumatic stress disorder	DPP6 DCC ZNF804A IPO9 KHDC1L PRKN	3.32e-04	202	134	6	EFO_0001358
Disease	pelvic organ prolapse	DPP6 ADAMTSL1 ARHGAP40 EYA1 SHC3	4.01e-04	136	134	5	EFO_0004710
Disease	serum IgG glycosylation measurement	DPP6 SORBS1 PTGFR ZNF804A FRY TAF3 ASAP2 PRKN CACNA1I	6.64e-04	523	134	9	EFO_0005193
Disease	cholesteryl esters to total lipids in small HDL percentage	CETP PCSK6 PCCB	9.90e-04	43	134	3	EFO_0022254
Disease	Intellectual Disability	RALGAPA1 AHI1 PTPN23 DCC KIF7 FRY PYCR1 PYCR2	1.03e-03	447	134	8	C3714756
Disease	amino acid metabolic disorder (is_implicated_in)	PCCA PCCB	1.10e-03	11	134	2	DOID:9252 (is_implicated_in)
Disease	C-reactive protein measurement	TRAF3IP2 AHI1-DT CETP CARMIL1 ANXA6 MCM2 CCDC168 CACHD1 IL22RA1 IPO9 PELO ZNF608 NTM PCCB	1.20e-03	1206	134	14	EFO_0004458
Disease	cognitive function measurement, self reported educational attainment	CARMIL1 TRIOBP DCC ZNF804A CACNA1I PCCB PREX1	1.22e-03	355	134	7	EFO_0004784, EFO_0008354
Disease	Ciliopathies	AHI1 BBS2 ACVR2B KIF7	1.62e-03	110	134	4	C4277690
Disease	cholesterol to total lipids in small HDL percentage	CETP PCSK6 PCCB	1.63e-03	51	134	3	EFO_0022240
Disease	lipoprotein A measurement	TAGAP CETP PRKN PCCB	1.73e-03	112	134	4	EFO_0006925
Disease	HSV2 virologic severity measurement	EYA1 PRKN	2.07e-03	15	134	2	EFO_0009010
Disease	omega-6 polyunsaturated fatty acid measurement	CETP NR2C2AP FER1L4 ALCAM PCCB	2.10e-03	197	134	5	EFO_0005680
Disease	sarcoidosis (is_implicated_in)	BTNL2 CTLA4	2.36e-03	16	134	2	DOID:11335 (is_implicated_in)
Disease	Bardet-Biedl syndrome 1 (disorder)	BBS2 KIF7	2.66e-03	17	134	2	C2936862
Disease	hearing threshold measurement, hearing measurement	LVRN TAF3 PRKN	2.72e-03	61	134	3	EFO_0007616, EFO_0007618
Disease	taurochenodeoxycholate measurement	EYA1 PTGER2	2.99e-03	18	134	2	EFO_0010537
Disease	Disorder of organic acid metabolism	PCCA PCCB	2.99e-03	18	134	2	cv:C1263739
Disease	disease free survival	CCDC168 XCL1	2.99e-03	18	134	2	EFO_0000409
Disease	Familial aplasia of the vermis	AHI1 KIF7	3.69e-03	20	134	2	cv:C0431399
Disease	synophrys measurement	ZNF608 GLIS1 PPP6R3	3.70e-03	68	134	3	EFO_0007906
Disease	Profound Mental Retardation	AHI1 DCC KIF7 FRY	3.77e-03	139	134	4	C0020796
Disease	Mental Retardation, Psychosocial	AHI1 DCC KIF7 FRY	3.77e-03	139	134	4	C0025363
Disease	Mental deficiency	AHI1 DCC KIF7 FRY	3.77e-03	139	134	4	C0917816
Disease	refractive error	SESTD1 ADAMTSL1 NTM FER1L4 CACNA1I PCCA	3.83e-03	326	134	6	MONDO_0004892
Disease	blood pressure	TNR PREX1	4.46e-03	22	134	2	EFO_0004325
Disease	Hepatitis	NTM XCL1	4.46e-03	22	134	2	HP_0012115

Protein segments in the cluster

Peptide	Gene	Start	Entry
IIRDKSVRNVSCSIN	BTN2A3P	206	Q96KV6
QSVICLSNIITITQR	CFAP54	1056	Q96N23
QINTQLTCDSGRVRT	CETP	141	P11597
SAEVRRRQCLQLSTV	C2orf69	46	Q8N8R5
ICLSIVSSSRGQVRR	C1QA	171	P02745
VSQTNRNLVCSALLT	CRYBG3	371	Q68DQ2
SLNSDRLRTVQLNVC	BDH1	101	Q02338
RLRTVQLNVCSSEEV	BDH1	106	Q02338
LVVRNASAESVSCLV	BTNL2	206	Q9UIR0
TLLRVTNISAVDVTC	BTNL2	421	Q9UIR0
QRLETVTEVIRSCAA	AHI1	981	Q8N157
SCATQRILALANRIT	GPR17	296	Q13304
VSRTISCDRLSTTVN	CACHD1	146	Q5VU97
VLTVADTVRTCSLDQ	CACHD1	266	Q5VU97
RTTFIQNRTIATLQC	C17orf78	56	Q8N4C9
RILTDIQNSSITCLR	ANKRD61	136	A6NGH8
TRCATRGLVNTLVNT	AHI1-DT	206	P0C7V0
VNITVRCTVATSRLL	LVRN	131	Q6Q4G3
EIPTSNIRRIICSTS	CD80	151	P33681
IITSRSNRQRQEVCQ	ANXA6	46	P08133
KTTNETRQLCFVVRS	IL13RA2	296	Q14627
SRRAELVCLNNTEIS	RAI14	461	Q9P0K7
ITSVCQSTRRFRDQI	HSPG2	526	P98160
VAALLERTQSTCQAR	PTPN23	686	Q9H3S7
NAVEASCIRTRELQS	PYCR1	256	P32322
RQIISATICNASIVL	KRT26	146	Q7Z3Y9
IVTSLQARCTVIAAA	MCM2	616	P49736
INRNSSVSRALRVCN	DUOX1	351	Q9NRD9
IVAVICTRRSSAQQR	DCC	1116	P43146
VVRCLSEQSVAISRC	ID1	31	P41134
VSTACQQLEVFSRVL	NELFCD	191	Q8IXH7
DCSLRTGQRSVQVSV	GREB1	1201	Q4ZG55
VICQDRSSLRQTVVR	GREB1	1901	Q4ZG55
SRVCTVLVSRTALQV	NTSR2	191	O95665
ESATLRCTIDNRVTR	NTM	51	Q9P121
VRAVLSLCQQTSRSQ	LRR1	26	Q96L50
FTTRTAQCRNTVAAI	ASAP2	26	O43150
ARVLISTQCQTTRVL	FER1L4	786	A9Z1Z3
QATCRRTLEVARTSL	IKBKE	451	Q14164
TLAEVLSRCSQNITE	IKBKE	501	Q14164
IVRCQVLLSFSQSVA	ADAMTSL1	546	Q8N6G6
VAVRQDTCSIVAISL	CPSF1	231	Q10570
LLSNTTCQTENRLSV	PTGFR	16	P43088
VQVLRTTALTSACAE	PCSK6	516	P29122
VVVDACSSRSQVDRL	ISOC2	131	Q96AB3
TLSEETCQQLARETL	PDE4A	221	P27815
CCRISLRTQDATQTS	PTGER2	331	P43116
VNSISNTRIQRDLCR	CSNKA2IP	436	A0A1B0GTH6
RGLCVVEQRSSVTSS	FAM214B	121	Q7L5A3
SRTNCVNILVTTTQL	EYA1	491	Q99502
EAITCRQRVLRASAS	KIF7	1061	Q2M1P5
RTQTFVNCSVVAAVR	LPAR6	256	P43657
SDCQQELSLVRTVTR	TEPSIN	241	Q96N21
SRSCTTQIRVIVADA	PCDHGB3	221	Q9Y5G1
SVDGTQRTVQCLSRE	PCCA	606	P05165
TVSEEGCRSRTILNR	GREM2	81	Q9H772
SRQKSEQLSRSLCEV	PCNT	2616	O95613
RASLETQRAQSSRLC	PCNT	2691	O95613
VSIIRCLSSSAVANR	F2R	291	P25116
VCGQERTSATLTIRA	OBSCN	3521	Q5VST9
LITSTNRTNRSACLD	OXGR1	171	Q96P68
ESRLLSISCSIENQI	OXGR1	266	Q96P68
LRAAVRSLCSQATSV	PCCB	21	P05166
RSLCSQATSVNERIE	PCCB	26	P05166
QTRANVTRLCQVTST	NEU2	116	Q9Y3R4
VVICLSTTVRNDTLQ	GLG1	776	Q92896
TRQVQLECVVLNRTS	IGSF3	831	O75054
LECVVLNRTSITSQL	IGSF3	836	O75054
TACRDAIRSNNINTL	BBS2	696	Q9BXC9
LSANLERESQRCVIT	CCDC175	441	P0C221
CQQEIESSRVELRSL	CCDC18	381	Q5T9S5
CRVVSEQLQARLETT	CROCC2	121	H7BZ55
NVQRIRSTSLESREC	FRMPD3	1381	Q5JV73
IICTQPRRISAISVA	DHX57	596	Q6P158
RVNCTLLRQATGSDT	CACNA1I	2001	Q9P0X4
CRLTTQRQEIESTNK	ITSN1	501	Q15811
TRQLRNSTLQCETIN	GCC2	1051	Q8IWJ2
SVSCSRLRQVQSILT	DNAAF9	26	Q5TEA3
CQRVGSRATTVSEII	ACSBG1	636	Q96GR2
VTQQSSLIARLERLC	ANGPTL6	171	Q8NI99
ADRAERQLQVISSSC	FBXO41	336	Q8TF61
ACQTRTLRFVSNVTE	INSRR	481	P14616
CQRITRKSCNLTVET	IL22RA1	71	Q8N6P7
LCATAIDILTTVVRN	IPO9	666	Q96P70
QLERCFTATGQTRVT	KHDC1L	56	Q5JSQ8
VTITCRASQGIRNDL	IGKV1-6	41	A0A0C4DH72
VTITCRASQGIRNDL	IGKV1-17	41	P01599
VTVLRQADSQVTEVC	CTLA4	71	P16410
STDVCEQILRVVSRS	CARMIL1	231	Q5VZK9
ELNVTVVTSLCRRSN	ELANE	171	P08246
VVTSLCRRSNVCTLV	ELANE	176	P08246
LRSISEQCRRVSSQV	ERMARD	536	Q5T6L9
IRIKCESNTATQSRL	FRY	416	Q5TBA9
RGITRFCLSSSTQQE	CCDC168	3876	Q8NDH2
RSSQTSLVTCVNGLR	GLIS1	91	Q8NBF1
RAQNVSILTLCDATT	DPP6	401	P42658
VITSNTIVRCRSCRT	SEC24B	596	O95487
VTLTCTAENQLERTV	ALCAM	481	Q13740
VCPETVSRVSSVLNR	NR2C2AP	6	Q86WQ0
RTCEQQLLNLSVSAR	OTOG	906	Q6ZRI0
STCEGVNTEVRTRLL	HES1	126	Q14469
TEENRTLRLAQSQCV	MAP3K7CL	111	P57077
SRSLLRVSVAQICQA	TAF3	6	Q5VWG9
VSSTRDLLIQTIENC	TRDMT1	126	O14717
TVSQESRRAETLVCC	SPAG5	531	Q96R06
TNSRNITCITCTDVR	PRKN	231	O60260
EDTTTLCLQSRRQKQ	SOCS5	326	O75159
TVSESVQRNKRDCLV	TAGAP	696	Q8N103
CTIRGRSLIQISIQE	PREX1	1266	Q8TCU6
TRTQITREAISRVCE	SHC3	176	Q92529
VVTLQQDITTERCRQ	FTSJ3	86	Q8IY81
CLQTSSLAVRVNSLV	SCYL2	496	Q6P3W7
ISACQVIAEAVRTTL	CCT7	26	Q99832
NAVEASCIRTRELQS	PYCR2	256	Q96C36
VGSNRVRTTLTLCVE	PELO	56	Q9BRX2
RSVNSRELSRIIICN	VHLL	46	Q6RSH7
TVRQVRESKCTSQAI	SIX6OS1	381	Q8N1H7
RTIQQENLRTSCTRQ	TRIOBP	761	Q9H2D6
ATVVLCQSLRCTSRS	SESTD1	561	Q86VW0
IRRSVNGTTSDCLVS	ACVR2B	481	Q13705
SRQVTCLRTQVLEDS	TRAF3IP2	86	O43734
VTVSARTNRRCQTAE	NCAPG	956	Q9BPX3
SNCLVERSNQVSLLR	SPATA45	31	Q537H7
TVATVVESALCALRN	PLK3	426	Q9H4B4
VSDKRTCVSLTTQRL	XCL1	26	P47992
INASLILTSQRISCS	ZNF321P	116	Q8N8H1
LTVCVSQTQANARAI	TMC8	611	Q8IU68
ASVLRIQTVIDECTQ	ZBTB45	106	Q96K62
QSVLRRTTQECPVRT	WWC2	1051	Q6AWC2
RQARVETISTDVCNR	TMPRSS11F	346	Q6ZWK6
STLTQTQVAAVCRRL	ARHGAP40	91	Q5TG30
VLNNTTLVSCIQIRS	RALGAPA1	1561	Q6GYQ0
RLLRSEKVCQTADTQ	RLF	1486	Q13129
RQNRVCTTVAIAIVA	SF3B1	1106	O75533
VVRCLSTEQRLSDLN	SORBS1	1156	Q9BX66
CQLEVTTERVQRQSV	TNR	31	Q92752
ASDSVLCIQVLSVIR	WDFY4	396	Q6ZS81
TRQSRRQICTSSLME	ZDBF2	31	Q9HCK1
ASQSLCDIIRLSREQ	PPP6R1	211	Q9UPN7
EQLLVRTRSVGVNTC	ZNF608	341	Q9ULD9
SCRQEDVIATANLSR	TLN2	2196	Q9Y4G6
AIICTSRSLNVRATV	TRAPPC8	1071	Q9Y2L5
SRSLNVRATVCRSNS	TRAPPC8	1076	Q9Y2L5
KRICSVSQISVRDSQ	TRAPPC9	36	Q96Q05
HTLVQQQRTLTTERC	ZNF154	146	Q13106
QCRNLTVSNTRTVLL	UBE4A	201	Q14139
SRVTQSILVLVSTLC	VN1R3	231	Q9BXE9
TNQVESLTQERRCRV	VWA7	426	Q9Y334
ASQSLCEIVRLSRDQ	PPP6R3	211	Q5H9R7
ISVDQRQVKTVRTCT	TRIM22	316	Q8IYM9
TVTVRENCNEISQRV	ZNF804A	141	Q7Z570
RACGVLETIRISAQS	MYO5C	671	Q9NQX4
VTTCNTRLDVTARPN	MYOT	431	Q9UBF9